Starling Oncology Inc. Common Stock
STLNUnited States
5 filed reports · 291 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
5 reports · Jun 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 4 | 1,275 | Jun 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 751 | Dec 2025 |
Financial data
291 concepts · 2,026 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial281 concepts · 1,756 facts · Mar 2024 to Jun 2026
- Thereafter16 · Jun 2025 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value12 · Mar 2024 to Jun 2026
- Net income loss12 · Mar 2024 to Jun 2026
- Stockholders equity (US GAAP)12 · Mar 2024 to Jun 2026
- Accounts receivable, bad debt recovery11 · Jun 2024 to Jun 2026
- Amortization of intangible assets11 · Jun 2024 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents11 · Jun 2024 to Jun 2026
- Depreciation11 · Jun 2024 to Jun 2026
- Depreciation and amortization11 · Jun 2024 to Jun 2026
- Derivative gain loss on derivative net11 · Jun 2024 to Jun 2026
- Fair value adjustment of warrants11 · Jun 2024 to Jun 2026
- Finance lease interest expense11 · Jun 2024 to Jun 2026
- Finance lease right of use asset amortization11 · Jun 2024 to Jun 2026
- Finance lease weighted average discount rate percent11 · Jun 2024 to Jun 2026
- Income tax expense benefit11 · Jun 2024 to Jun 2026
- Interest expense nonoperating11 · Jun 2024 to Jun 2026
- Net income loss available to common stockholders basic11 · Jun 2024 to Jun 2026
- Net income loss available to common stockholders diluted11 · Jun 2024 to Jun 2026
- Nonoperating income expense11 · Jun 2024 to Jun 2026
- Operating costs and expenses11 · Jun 2024 to Jun 2026
- Operating income loss11 · Jun 2024 to Jun 2026
- Operating lease cost11 · Jun 2024 to Jun 2026
- Operating lease weighted average discount rate percent11 · Jun 2024 to Jun 2026
- Other nonoperating income expense11 · Jun 2024 to Jun 2026
Segment6 concepts · 148 facts · Jun 2024 to Jun 2026
- Depreciation32 · Jun 2024 to Jun 2026
- Other operating income32 · Jun 2024 to Jun 2026
- Revenue32 · Jun 2024 to Jun 2026
- Amortization of intangible assets22 · Jun 2024 to Jun 2026
- Cost of goods and service excluding depreciation depletion and amortization18 · Sep 2024 to Jun 2026
- Direct operating costs12 · Jun 2024 to Dec 2025
Product3 concepts · 118 facts · Jun 2024 to Jun 2026
- Revenue54 · Jun 2024 to Jun 2026
- Cost of goods and service excluding depreciation depletion and amortization52 · Jun 2024 to Jun 2026
- Direct operating costs12 · Jun 2024 to Dec 2025
Geography1 concepts · 4 facts · Mar 2026 to Jun 2026
- Number of lease modifications4 · Mar 2026 to Jun 2026
Segments
270 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments4 members · 148 facts
- Clinical Trials And Other54 · Jun 2024 to Jun 2026
- Patient Services54 · Jun 2024 to Jun 2026
- Specialty Pharmacy24 · Dec 2024 to Jun 2026
- Dispensary16 · Jun 2024 to Sep 2025
Product or service10 members · 118 facts
- Clinical Research Trials And Other Revenue22 · Jun 2024 to Jun 2026
- Health Care Patient Service22 · Jun 2024 to Jun 2026
- Health Care Specialty Pharmacy12 · Dec 2024 to Jun 2026
- Capitated Revenue11 · Jun 2024 to Jun 2026
- Fee For Service11 · Jun 2024 to Jun 2026
- Clinician Salaries And Benefits10 · Jun 2024 to Jun 2026
- Intravenous IV Drug Costs10 · Jun 2024 to Jun 2026
- Medical Supplies And Other10 · Jun 2024 to Jun 2026
- Dispensary Revenue8 · Jun 2024 to Sep 2025
- Network Medical Expenses2 · Jun 2025 to Jun 2026
Statement geographical2 members · 4 facts
- CA2 · Mar 2026 to Jun 2026
- FL2 · Mar 2026 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 6, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.